Credit Suisse’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-67,325
| Closed | -$1.21M | – | 4249 |
|
|
2017
Q4 | $1.21M | Buy |
67,325
+34,361
| +104% | +$423K | ﹤0.01% | 2859 |
|
|
2017
Q3 | $388K | Buy |
32,964
+19,315
| +142% | +$217K | ﹤0.01% | 3618 |
|
|
2017
Q2 | $143K | Sell |
13,649
-51,856
| -79% | -$529K | ﹤0.01% | 3682 |
|
|
2017
Q1 | $721K | Sell |
65,505
-59,528
| -48% | -$691K | ﹤0.01% | 3078 |
|
|
2016
Q4 | $1.69M | Sell |
125,033
-11,747
| -9% | -$164K | ﹤0.01% | 2572 |
|
|
2016
Q3 | $1.68M | Sell |
136,780
-13,510
| -9% | -$159K | ﹤0.01% | 2512 |
|
|
2016
Q2 | $1.65M | Buy |
150,290
+115,219
| +329% | +$1.29M | ﹤0.01% | 2493 |
|
|
2016
Q1 | $383K | Sell |
35,071
-2,775
| -7% | -$35.1K | ﹤0.01% | 3385 |
|
|
2015
Q4 | $654K | Sell |
37,846
-25,121
| -40% | -$450K | ﹤0.01% | 3173 |
|
|
2015
Q3 | $1.25M | Buy |
62,967
+5,100
| +9% | +$117K | ﹤0.01% | 2626 |
|
|
2015
Q2 | $951K | Sell |
57,867
-19,966
| -26% | -$346K | ﹤0.01% | 3232 |
|
|
2015
Q1 | $1.21M | Buy |
77,833
+5,889
| +8% | +$91.3K | ﹤0.01% | 2817 |
|
|
2014
Q4 | $1.03M | Buy |
71,944
+57,826
| +410% | +$611K | ﹤0.01% | 3118 |
|
|
2014
Q3 | $91K | Sell |
14,118
-9,557
| -40% | -$63.5K | ﹤0.01% | 4308 |
|
|
2014
Q2 | $163K | Sell |
23,675
-28,832
| -55% | -$204K | ﹤0.01% | 4431 |
|
|
2014
Q1 | $375K | Buy |
52,507
+36,799
| +234% | +$315K | ﹤0.01% | 3925 |
|
|
2013
Q4 | $148K | Sell |
15,708
-9,928
| -39% | -$70.8K | ﹤0.01% | 4403 |
|
|
2013
Q3 | $160K | Sell |
25,636
-26,640
| -51% | -$166K | ﹤0.01% | 4028 |
|
|
2013
Q2 | $344K | Buy |
+52,276
| New | +$415K | ﹤0.01% | 3542 |
|
Other funds holding SCMP
Credit Suisse's SCMP Position: Q1 2018 in Review
Credit Suisse sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 67,325 shares — an estimated $1.21M sold.
Credit Suisse first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $1.69M in Q4 2016. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Credit Suisse reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Credit Suisse sold 67,325 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.21M.
- Credit Suisse first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- Credit Suisse's Sucampo Pharmaceuticals, Inc. position peaked at $1.69M in Q4 2016.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Credit Suisse's 13F filing for Q1 2018, filed 15 May 2018.